P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors
Poseida Therapeutics, Inc.
Poseida Therapeutics, Inc.
SystImmune Inc.
Novartis
Incyte Corporation
Xencor, Inc.
University of Wisconsin, Madison
National Cancer Institute (NCI)
Cancer Research UK